Google Alum’s AI Startup Raises $24 Million for Biotech Work
- European company uses generative AI to help design proteins
- Cradle plans to expand its team, add research facilities
This article is for subscribers only.
European biotech startup Cradle raised $24 million, gaining funds for its effort to use AI to help scientists design and engineer proteins faster and more cost-effectively.
Index Ventures led the Series A round, joined by Kindred Capital, Chris Gibson, the co-founder of Recursion Pharmaceuticals Inc., and Tom Glocer, the former chief executive officer of Thomson Reuters Corp. and a Merck & Co. board member, Cradle said Tuesday. The startup has raised a total of $33 million so far, including a seed round last year.